Healthcare -
Biotechnology - NASDAQ - US
$ 301.13
-1.23 %
$ 13.6 B
Market Cap
11.75
P/E
UTHR - REVENUE
Revenue UTHR - United Therapeutics Corporation
2.88 B
LAST VALUE
21.90%
2 YEAR CAGR
14.71%
5 YEAR CAGR
8.37%
10 YEAR CAGR